tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
BioArctic AB Class B (SE:BIOA.B)
:BIOA.B
Sweden Market
BIOA.B
BioArctic AB Class B
RESEARCH TOOLSreports

BioArctic AB Class B (BIOA.B) Stock News & Sentiment

Compare
3 Followers
BioArctic’s Leqembi Gains Inclusion in China’s Innovative Drug List
Premium
Company Announcements
BioArctic’s Leqembi Gains Inclusion in China’s Innovative Drug List
12d ago
BioArctic’s Lecanemab Shows Promise in Delaying Alzheimer’s Progression
Premium
Company Announcements
BioArctic’s Lecanemab Shows Promise in Delaying Alzheimer’s Progression
17d ago
BioArctic AB Expands Share Count Through Stock Option Program
Premium
Company Announcements
BioArctic AB Expands Share Count Through Stock Option Program
22d ago
BioArctic and Eisai Submit Subcutaneous Leqembi Application in Japan
Premium
Company Announcements
BioArctic and Eisai Submit Subcutaneous Leqembi Application in Japan
23d ago
Eisai Completes FDA Submission for Home-Use Alzheimer’s Treatment
Premium
Company Announcements
Eisai Completes FDA Submission for Home-Use Alzheimer’s Treatment
25d ago
BioArctic’s Lecanemab Data to be Unveiled at CTAD Conference
Premium
Company Announcements
BioArctic’s Lecanemab Data to be Unveiled at CTAD Conference
1M ago
BioArctic’s Alzheimer’s Treatment Leqembi Gains UK Approval for Maintenance Dosing
Premium
Company Announcements
BioArctic’s Alzheimer’s Treatment Leqembi Gains UK Approval for Maintenance Dosing
1M ago
More SE:BIOA.B News >

BIOA.B News on the Web

BioArctic AB Annual General Meeting Resolutions and New Incentive Program
TipRanks News
Neutral
Exploring High Growth Tech Stocks In Europe March 2025
Yahoo Finance
Neutral
The Committee for Medicinal Products for Human Use reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
Yahoo Finance
Neutral
High Insider Owned Growth Stocks With Earnings Up To 69%
Yahoo Finance
Neutral
Exploring Three High Growth Tech Stocks For Future Potential
Yahoo Finance
Neutral
Tikehau Capital And 2 More Stocks That May Be Priced Below Their Estimated Worth
Yahoo Finance
Neutral
3 Growth Companies Insiders Own With Earnings Growth Up To 51%
Yahoo Finance
Neutral
FDA approves IV maintenance dosing of Leqembi® for the treatment of early Alzheimer's Disease in the US
Yahoo Finance
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is SE:BIOA.B’s Media Buzz Sentiment?
Currently, no data Available
What is SE:BIOA.B’s weekly average amount of articles?
Currently, no data Available
What is SE:BIOA.B’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
CYTKCytokinetics
KYTXKyverna Therapeutics, Inc.
ANIPANI Pharmaceuticals
HIKHikma Pharmaceuticals
DBVTDBV Technologies SA - American
Showing the stocks with the most bullish news sentiment over the past week